Timber Hill’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-2,300
Closed -$256K 702
2017
Q2
$256K Sell
2,300
-11,400
-83% -$1.21M 0.01% 786
2017
Q1
$1.34M Buy
13,700
+500
+4% +$47.7K 0.01% 898
2016
Q4
$1.21M Buy
13,200
+3,400
+35% +$293K 0.01% 1161
2016
Q3
$829K Sell
9,800
-4,700
-32% -$395K ﹤0.01% 1218
2016
Q2
$1.18M Sell
14,500
-10,800
-43% -$822K 0.01% 1166
2016
Q1
$1.81M Sell
25,300
-9,300
-27% -$624K 0.01% 977
2015
Q4
$2.46M Buy
34,600
+26,900
+349% +$1.81M 0.01% 869
2015
Q3
$473K Sell
7,700
-17,400
-69% -$1.22M ﹤0.01% 1819
2015
Q2
$1.82M Sell
25,100
-200
-0.8% -$14.8K 0.01% 1120
2015
Q1
$1.94M Buy
25,300
+9,300
+58% +$666K 0.01% 1056
2014
Q4
$1.07M Sell
16,000
-44,700
-74% -$2.82M ﹤0.01% 1407
2014
Q3
$3.68M Sell
60,700
-31,500
-34% -$1.94M 0.02% 766
2014
Q2
$5.41M Sell
92,200
-5,000
-5% -$293K 0.02% 580
2014
Q1
$5.63M Buy
97,200
+42,500
+78% +$2.28M 0.02% 588
2013
Q4
$2.93M Buy
54,700
+29,200
+115% +$1.73M 0.01% 1103
2013
Q3
$1.58M Sell
25,500
-5,800
-19% -$347K 0.01% 1628
2013
Q2
$1.9M Buy
+31,300
New +$1.86M 0.01% 1475

Other funds holding DGX

Timber Hill's DGX Position: Q2 2017 in Review

Timber Hill sold out of Quest Diagnostics (DGX) in Q2 2017, closing a stake of 5,855 shares — an estimated $619K sold.

Timber Hill first reported a position in DGX in Q4 2013 and held it in 8 quarters. The position peaked at $1.98M in Q1 2014. 643 funds tracked by Wall St. Rank hold DGX as of Q2 2017.

  • Timber Hill reported no remaining Quest Diagnostics position as of Q2 2017 after selling out during the quarter.
  • Timber Hill sold 5,855 Quest Diagnostics shares in Q2 2017, an estimated $619K.
  • Timber Hill first reported a position in Quest Diagnostics in Q4 2013 and held it in 8 quarters.
  • Timber Hill's Quest Diagnostics position peaked at $1.98M in Q1 2014.
  • 643 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2017.

Based on Timber Hill's 13F filing for Q2 2017, filed 9 Aug 2017.